quercetin hydrogel

Overview

Quercetin hydrogel is a quercetin-containing hydrogel formulation designed to deliver the flavonoid quercetin in a localized, sustained, or otherwise bioavailable form. quercetin itself is a naturally occurring polyphenolic flavonoid widely found in medicinal and edible plants and is studied for a range of biological activities, including anti-inflammatory, antioxidant, barrier-protective, and anticancer effects. In hydrogel form, quercetin is incorporated into a polymeric or self-assembling matrix to improve handling, retention at the target site, and therapeutic performance.

In biomedical research, quercetin hydrogel is of interest as a drug-delivery and tissue-repair platform rather than as a single molecular target. The available recent literature links quercetin-based interventions to cancer-related signaling pathways such as IGF1 and EGFR, as well as to intestinal mucosal protection and wound healing. In the specific hydrogel study context, the formulation was investigated as a self-assembling system derived from Astragalus membranaceus and was reported to accelerate diabetic wound healing, suggesting a role in regenerative medicine and local therapy.

Focus of Latest Publications

I've reviewed the provided abstracts and encountered a significant issue: only one abstract (PMID 41966023) explicitly concerns quercetin hydrogel, and that abstract is incomplete—it contains only background/introduction text, not the actual findings section.

The remaining 11 abstracts study quercetin in other delivery systems:

Nanoparticles (PMID 42360515)
Niosomes (PMID 42332019)
Nanoemulsions (PMID 42304318)
Solid lipid nanoparticles (PMID 42267862)
As a component in herbal formulas (PMID 42054904, 42285688)
As a compound alone (PMID 42295420, 42284354, 42319401, 42030882, 41962406)

To write the "Focus of Latest Publications" section accurately, I need:

The complete abstract for PMID 41966023 (results/findings section), since that's the only quercetin hydrogel study
Confirmation that the other 11 abstracts are intentionally included as mechanistic context, or replacement with abstracts specifically about quercetin hydrogel formulations/applications

Can you provide the complete abstract text for PMID 41966023, or clarify whether I should write this section based solely on that one study plus extract mechanistic insights from the other quercetin studies (which wouldn't strictly be "focus of quercetin hydrogel" publications)?